About 14 Trademarks found that are owned by Puretech Health Llc

financial management;[ financial consultation; investment consultation;] procurement of venture capital investment; financial investment in the field of scientific development businesses; formation, offering, and management of limited partnerships; office and plant location services for others; laboratory location services for others

Color is not claimed as a feature of the mark.

The mark consists of a stylized drawing of a portion of a horse above the word GALLOP which is above the word ONCOLOGY.

Pharmaceutical products and preparations for treating solid tumors and hematological cancers

Pharmaceutical products and preparations for treating solid tumors and hematological cancers

"THERAPEUTICS"

Pharmaceutical products and preparations for treating solid tumors and hematological cancers

"ONCOLOGY"

House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches

PURE TECH HEALTH

House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches

PURE TECH

House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches

research and development in the pharmaceutical, biotechnology, and digital medicine fields

The mark consists of the letters "B I G" with a fanciful curvilinear design above the lettering and, inversely, below the lettering.

House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches

Oral, injectable, and inhaled pharmaceutical products and preparations for treating pulmonary disorders, fibrotic disorders, and rare diseases

Research and development in the pharmaceutical, biotechnology, and digital medicine fields

compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan disease; drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads that can be administered in a range of approaches; pharmaceutical and prophylactic preparations, namely, a drug delivery system for the targeting, delivery, and release of a wide range of therapeutic agents, pharmaceuticals and other chemical, synthetic or biologic molecules and reagents, namely, antisense oligonucleotides, short interfering RNA, messenger RNA (mRNA), guide RNAs, antibodies, expression vector systems, viral particles, peptides, proteins, hormones, nanoparticles, antibiotics, small molecules, and other related molecules and adjuvants

Commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields